Literature DB >> 11287577

Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.

J Nalbantoglu1, N Larochelle, E Wolf, G Karpati, H Lochmuller, P C Holland.   

Abstract

Significant levels of adenovirus (Ad)-mediated gene transfer occur only in immature muscle or in regenerating muscle, indicating that a developmentally regulated event plays a major role in limiting transgene expression in mature skeletal muscle. We have previously shown that in developing mouse muscle, expression of the primary Ad receptor CAR is severely downregulated during muscle maturation. To evaluate how global expression of CAR throughout muscle affects Ad vector (AdV)-mediated gene transfer into mature skeletal muscle, we produced transgenic mice that express the CAR cDNA under the control of the muscle-specific creatine kinase promoter. Five-month-old transgenic mice were compared to their nontransgenic littermates for their susceptibility to AdV transduction. In CAR transgenics that had been injected in the tibialis anterior muscle with AdVCMVlacZ, increased gene transfer was demonstrated by the increase in the number of transduced muscle fibers (433 +/- 121 in transgenic mice versus 8 +/- 4 in nontransgenic littermates) as well as the 25-fold increase in overall beta-galactosidase activity. Even when the reporter gene was driven by a more efficient promoter (the cytomegalovirus enhancer-chicken beta-actin gene promoter), differential transducibility was still evident (893 +/- 149 versus 153 +/- 30 fibers; P < 0.001). Furthermore, a fivefold decrease in the titer of injected AdV still resulted in significant transduction of muscle (253 +/- 130 versus 14 +/- 4 fibers). The dramatic enhancement in AdV-mediated gene transfer to mature skeletal muscle that is observed in the CAR transgenics indicates that prior modulation of the level of CAR expression can overcome the poor AdV transducibility of mature skeletal muscle and significant transduction can be obtained at low titers of AdV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287577      PMCID: PMC114173          DOI: 10.1128/JVI.75.9.4276-4282.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor.

Authors:  P Freimuth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

Authors:  Y Yang; S E Haecker; Q Su; J M Wilson
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

4.  Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants.

Authors:  G Acsadi; A Jani; J Huard; K Blaschuk; B Massie; P Holland; H Lochmüller; G Karpati
Journal:  Gene Ther       Date:  1994-09       Impact factor: 5.250

5.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

6.  Multiple adenovirus serotypes use alpha v integrins for infection.

Authors:  P Mathias; T Wickham; M Moore; G Nemerow
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

Authors:  H Lochmüller; B J Petrof; G Pari; N Larochelle; V Dodelet; Q Wang; C Allen; S Prescott; B Massie; J Nalbantoglu; G Karpati
Journal:  Gene Ther       Date:  1996-08       Impact factor: 5.250

8.  Stepwise dismantling of adenovirus 2 during entry into cells.

Authors:  U F Greber; M Willetts; P Webster; A Helenius
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

9.  Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants.

Authors:  J Huard; H Lochmüller; G Acsadi; A Jani; P Holland; C Guérin; B Massie; G Karpati
Journal:  Exp Mol Pathol       Date:  1995-04       Impact factor: 3.362

10.  The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.

Authors:  A Kass-Eisler; E Falck-Pedersen; D H Elfenbein; M Alvira; P M Buttrick; L A Leinwand
Journal:  Gene Ther       Date:  1994-11       Impact factor: 5.250

View more
  16 in total

1.  Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

Authors:  Debadyuti Ghosh; Michael A Barry
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Adenovirus transduction: More complicated than receptor expression.

Authors:  Priyanka Sharma; Prithy C Martis; Katherine J D A Excoffon
Journal:  Virology       Date:  2016-12-31       Impact factor: 3.616

4.  Adeno-associated virus serotype 9-mediated overexpression of extracellular superoxide dismutase improves recovery from surgical hind-limb ischemia in BALB/c mice.

Authors:  Amina Saqib; Konkal-Matt R Prasad; Arabindra B Katwal; John M Sanders; R John Lye; Brent A French; Brian H Annex
Journal:  J Vasc Surg       Date:  2011-07-02       Impact factor: 4.268

5.  Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL.

Authors:  Anthony E Civitarese; Paul S MacLean; Stacy Carling; Lyndal Kerr-Bayles; Ryan P McMillan; Anson Pierce; Thomas C Becker; Cedric Moro; Jean Finlayson; Natalie Lefort; Christopher B Newgard; Lawrence Mandarino; William Cefalu; Ken Walder; Greg R Collier; Matthew W Hulver; Steven R Smith; Eric Ravussin
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

6.  Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.

Authors:  Christian A Shaw; Nancy Larochelle; Roy W R Dudley; Hanns Lochmuller; Gawiyou Danialou; Basil J Petrof; George Karpati; Paul C Holland; Josephine Nalbantoglu
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

7.  Myosin light chain 3f attenuates age-induced decline in contractile velocity in MHC type II single muscle fibers.

Authors:  Jong-Hee Kim; Windy S Torgerud; Kelsey H H Mosser; Hiroyuki Hirai; Shuichi Watanabe; Atsushi Asakura; Ladora V Thompson
Journal:  Aging Cell       Date:  2011-12-29       Impact factor: 9.304

8.  Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat.

Authors:  Takeshi Kashimura; Makoto Kodama; Yuko Hotta; Junichi Hosoya; Kaori Yoshida; Takuya Ozawa; Ritsuo Watanabe; Yuji Okura; Kiminori Kato; Haruo Hanawa; Ryozo Kuwano; Yoshifusa Aizawa
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

Review 9.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

10.  Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid.

Authors:  Christoph Volpers; Christian Thirion; Volker Biermann; Stefanie Hussmann; Helmut Kewes; Patrick Dunant; Helga von der Mark; Andreas Herrmann; Stefan Kochanek; Hanns Lochmüller
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.